CLINICAL_TRIALS
research
· 2025-01-22
Clinical Trial Update: BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) [NA]
Summary
This clinical trial update notes that Terumo Europe N.V. is recruiting for a study of BioPearl microspheres loaded with doxorubicin to treat unresectable hepato…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Terumo Europe N.V. | Conditions: Hepatocellular Carcinoma Non-resectable | NA | Status: RECRUITING